Management of renal angiomyolipoma in patients with tuberous sclerosis complex

Oncology Reports

Volumn 10, Issue 1, 2003, Pages 237-241

  Simmons, J L ^a   Hussain, S A ^a   Riley, P ^a   Wallace, D M A ^a  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Angiogenesis inhibitors; Angiomyolipoma; Tuberous sclerosis complex

Indexed keywords

ADULT; ANGIOMYOLIPOMA; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; KIDNEY TUMOR; RADIOGRAPHY; TUBEROUS SCLEROSIS;

ADULT; ANGIOMYOLIPOMA; FEMALE; HUMANS; KIDNEY NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TUBEROUS SCLEROSIS;

EID: 0037581052     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.10.1.237     Document Type: Article

References (23)

1. Wiederholt WC, Gomez MR and Kurland LT: Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982. Neurology 35: 600-603, 1985. (Pubitemid 15085093)
2. Stillwell TJ, Gomez MR and Kelalis PP: Renal lesions in tuberous sclerosis. J Urol 138: 477-481, 1987. (Pubitemid 17146013)
3. Ewalt DH, Sheffield E, Sparagana SP, et al. Renal lesion growth in children with tuberous sclerosis complex. J Urol 160: 141-145, 1998. (Pubitemid 29479447)
4. Fryer AE, Chalmers A, Connor JM, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet i: 659-661, 1987.
5. Kandt RS, Haines JL, Smith M, et al: Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2: 37-41, 1992.
6. Neumann HPH, Kandt RS, Lips JM and Brauch H: Renal involvement in tuberous sclerosis and von Hippel-Lindau disease. In: Oxford Textbook of Clinical Nephrology. Davison AM, Camerou JS, Grünfeld JP, et al (eds). Vol. 3. 2nd edition. Oxford University Press, pp2483-2489, 1998.
7. Thomas PK: Inherited disorders. In: Oxford Textbook of Medicine. Weatherall DJ, Ledingham JGG and Warrell DA (eds). 3rd edition. Oxford University Press, pp3984-3989, 1996.
8. Roach ES, Smith M, Huttenlocher P, et al: Diagnostic criteria: tuberous sclerosis complex. Report of the Diagnostic Criteria Committee of the National Tuberous Sclerosis Association. J Child Neurol 7: 221-224, 1992.
9. Grignon DJ and Eble JN: Renal neoplasms. In: Heptinstall's Pathology of the Kidney. Jennette JC, Olson JL, Schwartz MM and Silva FG (eds). Vol. 2. 5th edition. Lippincott-Raven, New York, pp1541-1573, 1998.
10. Green AJ, Sepp T and Yates JRW: Clonality of tuberous sclerosis hamartomas shown by non-random X-chromosome inactivation. Hum Genet 97: 240-243, 1996. (Pubitemid 26034793)
11. Sherman JL, Hartman DS, Friedman AC, et al. Angiomyolipoma: computed tomographic-pathologic con-elation of 17 cases. Am J Roentgenol 137: 1221-1226, 1981. (Pubitemid 12235728)
12. Brodsky GL and Garnick MB: Renal tumours in the adult patient. In: Renal Pathology with Clinical and Functional Correlations. Tisher CC and Brenner BM (eds). 2nd edition. JB Lippincott Co., Philadelphia, pp1540-1577, 1994.
13. Neumann HPH: Case 18-1994: tuberous sclerosis. N Engl J Med 331: 813-814, 1994.
14. Chan KW and Chan KL: Spontaneous rupture of renal tumours presenting as surgical emergency. Br J Urol 71: 253-255, 1993. (Pubitemid 23102245)
15. Shepherd CW, Gomez MR, Lie JT and Crowson CS: Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66: 792-796, 1991.
16. Rehani MM and Berry M: Radiation doses in computed tomography: the increasing dose of radiation needs to be controlled. BMJ 320: 593-594, 2000.
17. Van Baal JG, Smits NJ, Keeman JN, et al: The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 152: 35-38, 1994. (Pubitemid 24175693)
18. Steiner MS, Goldman SM, Fishman EK and Marshall FF: The natural history of renal angiomyolipoma. J Urol 150: 1782-1786, 1993. (Pubitemid 24350798)
19. Kerbel RS: Some recent advances in preclinical aspects of treating cancer by inhibition of tumour angiogenesis. In: American Society of Clinical Oncology Educational Book (Spring). pp4-7, 1999.
20. Miller KD, Sweeney CJ and Sledge GW: Redefining the target: chemotherapeutics as antiangiogenics. J Clin Oncol 19: 1195-1206, 2001. (Pubitemid 32176298)
21. Browder T, Butterfield CE, Kräling BM, et al: Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 60: 1878-1886, 2000. (Pubitemid 30207647)
22. Kerbel RS, Klement G, Pritchard KI and Kamen B: Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncology clinic. Ann Oncol 13: 12-15, 2002. (Pubitemid 34436715)
23. Figg WD, Dahut W, Duray P, et al: A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer. Clin Cancer Res 7: 1888-1893, 2001. (Pubitemid 32994822)